Literature DB >> 6894592

Functional properties of an endothelial cell cofactor for thrombin-catalyzed activation of protein C.

W G Owen, C T Esmon.   

Abstract

Thrombin-catalyzed activation of Protein C is accelerated by a human endothelial cell surface cofactor. The cofactor occurs also on mouse hemangioma cells (a transformed endothelial cell line), but not on cultured human smooth muscle cells or fibroblasts. The cofactor remains bound to the cell surface during Protein C activation. The cofactor is saturable with respect to both Protein C (Km = 0.72 +/- 0.07 microM) and thrombin (Km = 0.48 +/- 0.05 nM). Diisopropylphosphoryl-thrombin is a competitive inhibitor of the cofactor-dependent reaction with Ki = 0.56 +/- 0.1 nM. Prothrombin Fragment 1, the peptide derived from prothrombin that retains phospholipid binding capacity, does not inhibit activation of Protein C when present in a 7:1 molar excess over Protein C. Platelet Factor 4 (20 microgram/ml) also fails to inhibit Protein C activation. It is concluded that the endothelial cell provides a surface on which Protein C can be activated under physiological conditions.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6894592

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

Review 1.  The interaction between complement component C4b-binding protein and the vitamin K-dependent protein S forms a link between blood coagulation and the complement system.

Authors:  M Hessing
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

2.  Activated protein C N-linked glycans modulate cytoprotective signaling function on endothelial cells.

Authors:  Fionnuala Ní Ainle; James S O'Donnell; Jennifer A Johnson; Laura Brown; Eimear M Gleeson; Owen P Smith; Roger J S Preston
Journal:  J Biol Chem       Date:  2010-11-02       Impact factor: 5.157

3.  Stability of the thrombin-thrombomodulin complex on the surface of endothelial cells from human saphenous vein or from the cell line EA.hy 926.

Authors:  A Beretz; J M Freyssinet; J Gauchy; D A Schmitt; C Klein-Soyer; C J Edgell; J P Cazenave
Journal:  Biochem J       Date:  1989-04-01       Impact factor: 3.857

4.  [Significance of the endothelium of the vascular wall for maintaining hemostasis].

Authors:  U Delvos; G Müller-Berghaus
Journal:  Klin Wochenschr       Date:  1985-12-16

5.  beta-Hydroxyaspartic acid in vitamin K-dependent protein C.

Authors:  T Drakenberg; P Fernlund; P Roepstorff; J Stenflo
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

6.  Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates.

Authors:  S R Hanson; J H Griffin; L A Harker; A B Kelly; C T Esmon; A Gruber
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

7.  Evidence of normal functional levels of activated protein C inhibitor in combined Factor V/VIII deficiency disease.

Authors:  W M Canfield; W Kisiel
Journal:  J Clin Invest       Date:  1982-12       Impact factor: 14.808

8.  Interaction of plasmin with endothelial cells.

Authors:  P I Bauer; R Machovich; K G Büki; E Csonka; S A Koch; I Horváth
Journal:  Biochem J       Date:  1984-02-15       Impact factor: 3.857

9.  Identification of the predominant glycosaminoglycan-attachment site in soluble recombinant human thrombomodulin: potential regulation of functionality by glycosyltransferase competition for serine474.

Authors:  B Gerlitz; T Hassell; C J Vlahos; J F Parkinson; N U Bang; B W Grinnell
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

10.  Suppression of hemostatic system activation by oral anticoagulants in the blood of patients with thrombotic diatheses.

Authors:  E M Conway; K A Bauer; S Barzegar; R D Rosenberg
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.